HMGB1 and liver dysplastic nodule: In summary, expression of supra-physiological amounts of esRAGE via administration of rAAV-esRAGE, and treatment with recombinant HMGB1 A Box were successful in attenuating kidney inflammation and damage in a murine model of DN.